Concepedia

Dawn Colburn

DC

Statistics

Publications

11

Citations

640

H-Index

11

Active since

2001

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Roche (United Kingdom)

The Barbara Ann Karmanos Cancer Institute

Roche (Switzerland)

Theravance Biopharma (United States)

Dawn Colburn is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

2001–2018

11

Publications

11

Mylotarg? (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

Francis J. Giles, H. Kantarjian, Steve Kornblau et al. · Cancer · 2001 · 280 citations

Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors

Patricia LoRusso, Antonio Jimeno, Grace K. Dy et al. · Clinical Cancer Research · 2011 · 89 citations · Full text

Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects

Richard Graham, Cornelis E. C. A. Hop, Marie T. Borin et al. · British Journal of Clinical Pharmacology · 2012 · 58 citations · Full text

<i>In Vitro</i>Evaluation of Cytochrome P450-mediated Drug Interactions between Cytarabine, Idarubicin, Itraconazole and Caspofungin

Dawn Colburn, Francis J. Giles, Debra Oladovich et al. · Hematology · 2004 · 47 citations · Full text

Skin Infiltration with Chronic Lymphocytic Leukemia is Consistent with a Good Prognosis

Dawn Colburn, Mary-Alma Welch, Francis J. Giles · Hematology · 2002 · 46 citations · Full text

1–5 of 11